City Holding Co’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-20
| Closed | -$939 | – | 470 |
|
|
2024
Q3 | $939 | Sell |
20
-55
| -73% | -$2.58K | ﹤0.01% | 449 |
|
|
2024
Q2 | $4.05K | Sell |
75
-10
| -12% | -$540 | ﹤0.01% | 427 |
|
|
2024
Q1 | $5.79K | Sell |
85
-29
| -25% | -$1.98K | ﹤0.01% | 431 |
|
|
2023
Q4 | $7.14K | Sell |
114
-60
| -34% | -$3.76K | ﹤0.01% | 429 |
|
|
2023
Q3 | $7.89K | Sell |
174
-1,570
| -90% | -$71.2K | ﹤0.01% | 426 |
|
|
2023
Q2 | $97.9K | Sell |
1,744
-500
| -22% | -$28.1K | 0.02% | 274 |
|
|
2023
Q1 | $101K | Sell |
2,244
-670
| -23% | -$30.3K | 0.02% | 259 |
|
|
2022
Q4 | $118K | Sell |
2,914
-465
| -14% | -$18.9K | 0.02% | 248 |
|
|
2022
Q3 | $221K | Sell |
3,379
-360
| -10% | -$23.5K | 0.04% | 214 |
|
|
2022
Q2 | $227K | Sell |
3,739
-3,535
| -49% | -$215K | 0.04% | 207 |
|
|
2022
Q1 | $457K | Sell |
7,274
-190
| -3% | -$11.9K | 0.07% | 177 |
|
|
2021
Q4 | $458K | Buy |
7,464
+377
| +5% | +$23.1K | 0.08% | 173 |
|
|
2021
Q3 | $793K | Buy |
7,087
+2,873
| +68% | +$321K | 0.14% | 140 |
|
|
2021
Q2 | $682K | Buy |
4,214
+1,167
| +38% | +$189K | 0.12% | 140 |
|
|
2021
Q1 | $371K | Buy |
+3,047
| New | +$371K | 0.07% | 164 |
|